These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 16831988)
1. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Manji RA; Zhu LF; Nijjar NK; Rayner DC; Korbutt GS; Churchill TA; Rajotte RV; Koshal A; Ross DB Circulation; 2006 Jul; 114(4):318-27. PubMed ID: 16831988 [TBL] [Abstract][Full Text] [Related]
2. Bioprosthetic cardiac valve degeneration: role of inflammatory and immune reactions. Gong G; Seifter E; Lyman WD; Factor SM; Blau S; Frater RW J Heart Valve Dis; 1993 Nov; 2(6):684-93. PubMed ID: 7719511 [TBL] [Abstract][Full Text] [Related]
3. Role of elastin in pathologic calcification of xenograft heart valves. Bailey MT; Pillarisetti S; Xiao H; Vyavahare NR J Biomed Mater Res A; 2003 Jul; 66(1):93-102. PubMed ID: 12833435 [TBL] [Abstract][Full Text] [Related]
4. Nanocoating with titanium reduces iC3b- and granulocyte-activating immune response against glutaraldehyde-fixed bovine pericardium: a new technique to improve biologic heart valve prosthesis durability? Guldner NW; Bastian F; Weigel G; Zimmermann H; Maleika M; Scharfschwerdt M; Rohde D; Sievers HH J Thorac Cardiovasc Surg; 2012 May; 143(5):1152-9. PubMed ID: 22153860 [TBL] [Abstract][Full Text] [Related]
5. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. Weissenstein C; Human P; Bezuidenhout D; Zilla P J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041 [TBL] [Abstract][Full Text] [Related]
6. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification. Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882 [TBL] [Abstract][Full Text] [Related]
10. Mitigated calcification of glutaraldehyde-fixed bovine pericardium by tannic acid in rats. Wang D; Jiang H; Li J; Zhou JY; Hu SS Chin Med J (Engl); 2008 Sep; 121(17):1675-9. PubMed ID: 19024098 [TBL] [Abstract][Full Text] [Related]
11. Bioprosthetic heart valves: the need for a quantum leap. Zilla P; Human P; Bezuidenhout D Biotechnol Appl Biochem; 2004 Aug; 40(Pt 1):57-66. PubMed ID: 15270708 [TBL] [Abstract][Full Text] [Related]
12. Tissue damage and calcification may be independent mechanisms of bioprosthetic heart valve failure. Vesely I; Barber JE; Ratliff NB J Heart Valve Dis; 2001 Jul; 10(4):471-7. PubMed ID: 11499593 [TBL] [Abstract][Full Text] [Related]
13. A new model to test the calcification characteristics of bioprosthetic heart valves. Ozaki S; Herijgers P; Flameng W Ann Thorac Cardiovasc Surg; 2004 Feb; 10(1):23-8. PubMed ID: 15008695 [TBL] [Abstract][Full Text] [Related]
14. Is the tricuspid position suitable for testing replacement bioprosthetic valves in the sheep model? Pettenazzo E; Thiene G; Gatti AM; Pasquino E; Talenti E; Noera G; Bottio T; Valente M J Heart Valve Dis; 2001 Jul; 10(4):513-9. PubMed ID: 11499599 [TBL] [Abstract][Full Text] [Related]
15. Treatment of bioprosthetic heart valve tissue with long chain alcohol solution to lower calcification potential. Pathak CP; Adams AK; Simpson T; Phillips RE; Moore MA J Biomed Mater Res A; 2004 Apr; 69(1):140-4. PubMed ID: 14999761 [TBL] [Abstract][Full Text] [Related]
16. Octanediol treatment of glutaraldehyde fixed bovine pericardium: evidence of anticalcification efficacy in the subcutaneous rat model. Pettenazzo E; Valente M; Thiene G Eur J Cardiothorac Surg; 2008 Aug; 34(2):418-22. PubMed ID: 18550382 [TBL] [Abstract][Full Text] [Related]
17. [Using chemical methods to crosslink xenogeneic heart valves: the progress of bioprosthetic heart valves]. Lin L; Tang YW; Chang R; Zhou JY; Cui JW; Hu SS; Zhang FS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):735-7. PubMed ID: 14714325 [TBL] [Abstract][Full Text] [Related]